Market Snapshot

Study Period: | 2018 - 2026 |
Base Year: | 2021 |
Fastest Growing Market: | Asia Pacific |
Largest Market: | North America |
CAGR: | 5.8 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
Market Overview
Veterinary drugs are the drugs used in the treatment of numerous diseases growing in animals. Veterinary drugs such as antibiotics, antimicrobials, antihistamines, antiprotozoals and hormones are developed in order to minimize the attack of harmful virus and bacterial parasites in animals.
According to American Pet Products Association (APPA), 67% percent of United States households own a pet and estimated that 78 million dogs and 85.8 million cats are owned in the United States. Therefore the presence of advanced cost-effective veterinary drugs and rising clinical animal researches are the key driving factors in the veterinary drug market.
Scope of the Report
As per the scope of the report veterinary drugs are used in the treatment of numerous diseases growing in animals. Veterinary drugs such as antibiotics, antimicrobials, antihistamines, antiprotozoals and hormones are developed in order to minimize the attack of harmful virus and bacterial parasites in animals.
By Product Type | |
Anti-infectives | |
Anti-inflammatory | |
Parasiticides | |
Vaccines | |
Other Types |
By Route of Administration | |
Oral | |
Parenteral | |
Topical |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Key Market Trends
Parasiticides Segment is Expected to be a Fastest Growing Segment in the Veterinary Drugs Market
Parasites are organisms that survive by attacking pets and farm animals for nourishment and live in or on the body, benefiting from food and protection. Common parasites such as ticks, mosquitos and fleas live outside the body on the skin or hidden in an animal’s fur which not only harm the animal, they can quickly spread a disease outbreak. For instance, the Rift Valley Fever is an endemic zoonotic disease in Africa and the Middle East that costs producers USD 427 million every year.
Hence, owing to aforementioned factors, along with rise in prevalence of infectious diseases and increase in pet ownership, the parasiticides segment hold a significant market share and is anticipated to show similar trend over the forecast period.

To understand key trends, Download Sample Report
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a major market share in the global veterinary drugs market due to a rise in the prevalence of infectious diseases and the emergence of new technologies in this region. North America held the highest share and is also expected to continue dominating the market through the forecast period. Moreover, the introduction of new animal-related products and increasing adoption of animals is fueling the growth of the overall regional market to a large extent.

To understand geography trends, Download Sample Report
Competitive Landscape
The veterinary drug market is moderately consolidated and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Bayer AG, Zoetis Animal Healthcare, Virbac S.A, Boehringer Ingelheim International GmbH, Ceva, Vetoquinol S.A, Merck Ltd, Elanco, Intervet Inc and Bimeda, Inc
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Assumptions
-
1.2 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Rise in Prevalence of Infectious Diseases
-
4.2.2 Emergence of New Technologies, especially in Biologics
-
-
4.3 Market Restraints
-
4.3.1 Lack of Veterinarians
-
4.3.2 Use of Counterfeit Medicines
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Product Type
-
5.1.1 Anti-infectives
-
5.1.2 Anti-inflammatory
-
5.1.3 Parasiticides
-
5.1.4 Vaccines
-
5.1.5 Other Types
-
-
5.2 By Route of Administration
-
5.2.1 Oral
-
5.2.2 Parenteral
-
5.2.3 Topical
-
-
5.3 Geography
-
5.3.1 North America
-
5.3.1.1 United States
-
5.3.1.2 Canada
-
5.3.1.3 Mexico
-
-
5.3.2 Europe
-
5.3.2.1 Germany
-
5.3.2.2 United Kingdom
-
5.3.2.3 France
-
5.3.2.4 Italy
-
5.3.2.5 Spain
-
5.3.2.6 Rest of Europe
-
-
5.3.3 Asia-Pacific
-
5.3.3.1 China
-
5.3.3.2 Japan
-
5.3.3.3 India
-
5.3.3.4 Australia
-
5.3.3.5 South Korea
-
5.3.3.6 Rest of Asia-Pacific
-
-
5.3.4 Middle-East and Africa
-
5.3.4.1 GCC
-
5.3.4.2 South Africa
-
5.3.4.3 Rest of Middle-East and Africa
-
-
5.3.5 South America
-
5.3.5.1 Brazil
-
5.3.5.2 Argentina
-
5.3.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Bayer AG
-
6.1.2 Zoetis Inc.
-
6.1.3 Virbac S.A
-
6.1.4 Boehringer Ingelheim International GmbH (Merial)
-
6.1.5 Elanco
-
6.1.6 Ceva
-
6.1.7 Vetoquinol S.A
-
6.1.8 Bimeda, Inc (Bimeda Holdings PLC)
-
6.1.9 Merck & Co., Inc.
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Veterinary Drugs Market market is studied from 2018 - 2026.
What is the growth rate of Veterinary Drugs Market?
The Veterinary Drugs Market is growing at a CAGR of 5.8% over the next 5 years.
Which region has highest growth rate in Veterinary Drugs Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Veterinary Drugs Market?
North America holds highest share in 2021.
Who are the key players in Veterinary Drugs Market?
Bayer AG, Zoetis, Elanco, Virbac S.A, Boehringer Ingelheim International GmbH (Merial) are the major companies operating in Veterinary Drugs Market.